Joint Response Submitted by the Medical Research Council, The

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Joint response submitted by the Medical Research Council, the Wellcome Trust, Wellcome Trust Sanger Institute, the Institute of Cancer Research, Cancer Research UK, the Royal Society, the Sainsbury Laboratory, The Francis Crick Institute and the Association of the British Pharmaceutical Industry PURPOSE On 19 November 2012, representatives from the Medical Research Council and partner organisations listed above met to discuss the current Migration Advisory Committee (MAC) call for evidence. At this meeting, it was agreed that the current Shortage Occupation Lists needed to reflect emerging areas of science where it has been identified that there is a specific worldwide skill shortage impacting on UK scientific research. The intention of this joint response to the call for evidence is to put forward a justification for including bio-informaticians/computational biologists on the shortage occupation lists, under code of practice 2119 of the Office for National Statistics SOC 2010. We all share a belief about the critical importance of this discipline to UK science and our own organisations; with the worldwide shortage of top quality researchers in this area it is critical to ask the UK Government to support us and the scientific community in recognising these shortages and to provide the appropriate tools in order to further promote the high impact research we all engage in. Additionally, we present an argument as to why the Sunset Clause should not be implemented in respect of the research and scientific based occupations incorporated onto the shortage occupation lists. Background In a wide ranging speech1 on science, technology and growth, the Chancellor recently set out the major challenges facing the UK’s (life) science as a result of the upsurge in the availability of data. He said: The next generation of scientific discovery will be data-driven discovery, as previously unrecognised patterns are discovered by analysing massive data sets. The world already creates 2.5 quintillion bytes of data – equivalent to 150,000 full iPads – every single day. We need to make sure we capture value from this mass of data – both for economic growth and for social advances, such as better health. This requires a transformation in data management. The UK is well placed for the big data revolution. We have 25 of the world’s 500 most powerful computers. But crude computing power is not the be all and end all. We have a comparative advantage in IT because of three distinctive strengths. 1 Rt Hon George Osborne MP address to Royal Society, 9 November 2012, http://www.hm- treasury.gov.uk/speech_chx_091112.htm Medical Research Council, 14th Floor, One Kemble Street, London WC2B 4AN telephone +44 (0)1793 416200 www.mrc.ac.uk Page 2 of 9 First, we are good at the algorithms needed to handle these large data sets. The key role of British scientists in research projects which generate very large data- sets, such as the search for the Higgs boson at CERN, has led to the UK sustaining our world-leading strengths in the software development and algorithms needed to make sense of these massive data-sets. Secondly, we have some of the world’s best and most complete data-sets in healthcare, demographics, environmental change and food. Thirdly, these strengths are complemented by our strong life sciences sector. The future is linking “dry” computer sciences and “wet” biological sciences. The world’s key DNA sequencing technologies all come from British research labs. We can be a world leader in harnessing genetic data. At the same time, and referenced in his speech, the Research Councils UK launched their Strategic Framework for Capital Investment2 which highlights the capital infrastructure needs to deliver these big challenges. The proposals urge for a strong investment in so- called e-infrastructure. However, in his foreword the Chair of the Research Councils UK, Professor Rick Rylance, draws attention to the fact that infrastructure alone can not address the enormity of the challenge: “a flexible highly-skilled workforce with state of the art technical skills and research leadership is required across all career stages to enhance the excellence of the research base and deliver benefit for the UK economy. Investment in skills, capacity and capability are all crucial to the sustainability of research excellence and contribute to making the UK an attractive place to invest and grow business.” A recent report for the UK e-Infrastructure Leadership Council3 identified a common theme amongst their contributors and responders. It is clear that there is not an adequate ‘pipeline’ of talented individuals to work in research that deals with this ‘data deluge’. The report highlights the problems in the current educational system and calls for concerted effort to train these relatively new specialists. What is bio-informatics? Informatics is the discipline which combines scientific, computer science and statistical knowledge. It manages, integrates, manipulates and analyses large data sets which result for instance from sequencing large volumes of genomes or data that results from advancements in imaging techniques. Informatics is used throughout all scientific disciplines, not just the life sciences. However, on this occasion, we are particularly interested in making the case for life and medical sciences and our current and future workforce. Bio-informatics is of particular importance to research activities in the areas of Translational Medicine and e-Health. Both areas are described in detail in the aforementioned e-Infrastructure Leadership Council report. Furthermore it is also an important and growing area within pharmaceutical companies and contract research 2 http://www.rcuk.ac.uk/Publications/policy/Pages/CapitalInvestment.aspx 3 http://www.bis.gov.uk/assets/biscore/science/docs/e/12-1245-e-science-and-e-infrastructure- needs-uk-life-sciences-industries.pdf Page 3 of 9 organisations and hence there is also a high demand for people with these skills for the life science industry4. Bio-informaticians use algorithms (software), statistics and high performance computing (hardware) to do their roles. They require very specific software environments and may be involved in writing these. Some bio-informaticians perform a service to research groups, storing, analysing and interpreting the data. Others, typically called ‘computational biologists’, lead their own research and focus on applying the computational approaches to address the most important questions of the day. This is a developing field and various other job titles are used, which all relate to the similar, yet often quite varied, disciplines. Often used job titles are bio-informatician, statistical geneticist, neuroinformatician, health informatician, genome and next- generation sequencing data analyst, computer biologist, bio-statistician, scientific database curator, bio-informatics engineer, biosoftware support engineer, genome analyst and lab information management system programmer. Skills base The MRC and signatories to this consultation response find that when trying to employ or support these highly skilled individuals there is a worldwide critical shortage in capacity and skills. Bioinformatics is a relatively new field but has driven some of the most important recent advances in genomics and more generally biology. Although there is some training offered at the undergraduate and postdoctoral level there is an increasing demand for proficiency in bioinformatics that is not met by the current professional base in the UK. It is important to remark here that the UK has been leading the development of novel and innovative approaches in bioinformatics. There are few conventional university programmes that teach bio-informatics, although a number of master courses are appearing. Recruits tend to come from a biology background with a strong interest in computer programming and mathematics; others come from a more computational background with a strong interest in biology. They are typically educated to PhD level, although those performing ‘service functions’ can be of degree or post-grad calibre. The MRC receives over 70 applications for posts in this area which are described as ‘early career stage’ or training posts (broadly speaking no more than 3 years post PhD completion). The composition of this group is diverse, from all areas of the world. These candidates are not yet proficient in bio-informatics but demonstrate a desire and an ability to be ‘trained up’. At the later career stages (3 years plus post PhD completion) it becomes evident that there are not sufficient ‘early stage’ bio-informaticians being trained up. Applications drop to approximately 15 per advert with the majority of candidates being non-EU nationals. 4 http://www.abpi.org.uk/our‐work/library/industry/Pages/skills‐biomedical‐research.aspx. Page 4 of 9 The signatories who employ bio-informaticians are currently experiencing severe problems in appointing to leadership positions in this area. At this point in their career, we expect scientists to lead their own research group and have an independent research programme, funded through the usual peer review processes. These leaders tend to have at least 7 years experience since completion of their PhD. MRC are currently unable to fill at least 3 of these leadership positions at prestigious research institutes such as the MRC Clinical Sciences Centre in London and the MRC Functional Genomics Unit in Oxford. The competition for rare talent is intense. Our units and institutes do their utmost to create the ultimate environment in which scientists can flourish. This includes tangible benefits such as high tech infrastructure and less tangible features such as the research environment (e.g. working with like-minded people, offering the highest possible standing in research). Despite positioning the employment offer in a competitive way (insofar our pay structures and policies will allow) it does not result in the successful filling of these posts. Problems in recruitment at the more senior end of the career path result in fewer ‘trainers’ to educate and mentor the new intake of bio-informaticians, leading to a vicious circle of talent shortage.
Recommended publications
  • The for Report 07-08

    The for Report 07-08

    THE CENTER FOR INTEGRATIVE GENOMICS REPORT 07-08 www.unil.ch/cig Table of Contents INTRODUCTION 2 The CIG at a glance 2 The CIG Scientific Advisory Committee 3 Message from the Director 4 RESEARCH 6 Richard Benton Chemosensory perception in Drosophila: from genes to behaviour 8 Béatrice Desvergne Networking activity of PPARs during development and in adult metabolic homeostasis 10 Christian Fankhauser The effects of light on plant growth and development 12 Paul Franken Genetics and energetics of sleep homeostasis and circadian rhythms 14 Nouria Hernandez Mechanisms of basal and regulated RNA polymerase II and III transcription of ncRNA in mammalian cells 16 Winship Herr Regulation of cell proliferation 18 Henrik Kaessmann Mammalian evolutionary genomics 20 Sophie Martin Molecular mechanisms of cell polarization 22 Liliane Michalik Transcriptional control of tissue repair and angiogenesis 24 Alexandre Reymond Genome structure and expression 26 Andrzej Stasiak Functional transitions of DNA structure 28 Mehdi Tafti Genetics of sleep and the sleep EEG 30 Bernard Thorens Molecular and physiological analysis of energy homeostasis in health and disease 32 Walter Wahli The multifaceted roles of PPARs 34 Other groups at the Génopode 37 CORE FACILITIES 40 Lausanne DNA Array Facility (DAFL) 42 Protein Analysis Facility (PAF) 44 Core facilities associated with the CIG 46 EDUCATION 48 Courses and lectures given by CIG members 50 Doing a PhD at the CIG 52 Seminars and symposia 54 The CIG annual retreat 62 The CIG and the public 63 Artist in residence at the CIG 63 PEOPLE 64 1 Introduction The Center for IntegratiVE Genomics (CIG) at A glance The Center for Integrative Genomics (CIG) is the newest depart- ment of the Faculty of Biology and Medicine of the University of Lausanne (UNIL).
  • Massive Turnover of Functional Sequence in Human and Other Mammalian Genomes

    Massive Turnover of Functional Sequence in Human and Other Mammalian Genomes

    Downloaded from genome.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Research Massive turnover of functional sequence in human and other mammalian genomes Stephen Meader,1 Chris P. Ponting,1,3 and Gerton Lunter1,2,3 1MRC Functional Genomics Unit, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford OX1 3QX, United Kingdom; 2The Wellcome Trust Centre for Human Genetics, Oxford OX3 7BN, United Kingdom Despite the availability of dozens of animal genome sequences, two key questions remain unanswered: First, what fraction of any species’ genome confers biological function, and second, are apparent differences in organismal complexity reflected in an objective measure of genomic complexity? Here, we address both questions by applying, across the mammalian phylogeny, an evolutionary model that estimates the amount of functional DNA that is shared between two species’ genomes. Our main findings are, first, that as the divergence between mammalian species increases, the predicted amount of pairwise shared functional sequence drops off dramatically. We show by simulations that this is not an artifact of the method, but rather indicates that functional (and mostly noncoding) sequence is turning over at a very high rate. We estimate that between 200 and 300 Mb (;6.5%–10%) of the human genome is under functional constraint, which includes five to eight times as many constrained noncoding bases than bases that code for protein. In contrast, in D. melanogaster we estimate only 56–66 Mb to be constrained, implying a ratio of noncoding to coding constrained bases of about 2. This suggests that, rather than genome size or protein-coding gene complement, it is the number of functional bases that might best mirror our naı¨ve preconceptions of organismal complexity.
  • X CRG Annual Symposium

    X CRG Annual Symposium

    X CRG SYMPOSIUM 10-11 November 2011 COMPUTATIONAL BIOLOGY OF MOLECULAR SEQUENCES Organizers: R.Guigó, C.Notredame, T.Gabaldón, F.Kondrashov, G.G.Tartaglia Thursday 10 November 08:00 – 09:00 Registration 09:00 – 09:05 Welcome by Luis Serrano 09:05 – 09:15 Introduction by Roderic Guigó Session 1: Protein Analysis Chair: Gian Gaetano Tartaglia 09:15 – 10:00 Temple F. SMITH Department of Biomedical Engineering, Boston University, Boston US “A Unique Mammalian Apoptosis Regulatory Gene, Lfg5, and a Homo sapiens Neanderthal Mystery” 10:00 – 10:45 Michele VENDRUSCOLO Department of Chemistry, University of Cambridge, Cambridge UK “Life on the edge: Proteins are close to their solubility limits” 10:45 – 11:30 Amos BAIROCH Swiss Institute of Bioinformatics, and Department of Structural Biology and Bioinformatics, Faculty of Medicine, University of Geneva, Geneva CH “Organising human protein-centric knowledge: the challenge of neXtProt” 11:30 – 12:00 Coffee break Session 2: Genome Evolution Chair: Fyodor Kondrashov 12:00 – 12:45 Eugene V. KOONIN National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda (MD) USA “Are there laws in evolutionary genomics?” 12:45 – 13:30 Nick GOLDMAN EMBL - European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton UK “Adventures in Evolutionary Alignment” 13:30 – 15:00 Lunch 15:00 – 15:45 Mathieu BLANCHETTE School of Computer Science, McGill University, Montreal CA “Ancestral Mammalian Genome Reconstruction and its Uses toward Annotating the Human
  • Novel Protein Domains and Repeats in Drosophila Melanogaster: Insights Into Structure, Function, and Evolution

    Novel Protein Domains and Repeats in Drosophila Melanogaster: Insights Into Structure, Function, and Evolution

    Downloaded from genome.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Article Novel Protein Domains and Repeats in Drosophila melanogaster: Insights into Structure, Function, and Evolution Chris P. Ponting,1,4 Richard Mott,2 Peer Bork,3 and Richard R. Copley3 1MRC Functional Genetics Unit, Department of Human Anatomy and Genetics, University of Oxford, Oxford OX1 3QX, UK; 2Wellcome Trust Centre for Human Genetics, Oxford OX37BN, UK; 3European Molecular Biology Laboratory, 69012 Heidelberg, Germany Sequence database searching methods such as BLAST, are invaluable for predicting molecular function on the basis of sequence similarities among single regions of proteins. Searches of whole databases however, are not optimized to detect multiple homologous regions within a single polypeptide. Here we have used the prospero algorithm to perform self-comparisons of all predicted Drosophila melanogaster gene products. Predicted repeats, and their homologs from all species, were analyzed further to detect hitherto unappreciated evolutionary relationships. Results included the identification of novel tandem repeats in the human X-linked retinitis pigmentosa type-2 gene product, repeated segments in cystinosin, associated with a defect in cystine transport, and ‘nested’ homologous domains in dysferlin, whose gene is mutated in limb girdle muscular dystrophy. Novel signaling domain families were found that may regulate the microtubule-based cytoskeleton and ubiquitin-mediated proteolysis, respectively. Two families of glycosyl hydrolases were shown to contain internal repetitions that hint at their evolution via a piecemeal, modular approach. In addition, three examples of fruit fly genes were detected with tandem exons that appear to have arisen via internal duplication.
  • Big Knowledge from Big Data in Functional Genomics

    Big Knowledge from Big Data in Functional Genomics

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Edinburgh Research Explorer Edinburgh Research Explorer Big knowledge from big data in functional genomics Citation for published version: Ponting, C 2017, 'Big knowledge from big data in functional genomics' Emerging Topics in Life Sciences . DOI: 10.1042/ETLS20170129 Digital Object Identifier (DOI): 10.1042/ETLS20170129 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Emerging Topics in Life Sciences Publisher Rights Statement: This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and the Royal Society of Biology and distributed under the Creative Commons Attribution License 4.0 (CC BY). General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 05. Apr. 2019 Emerging Topics in Life Sciences (2017) 1 245–248 https://doi.org/10.1042/ETLS20170129 Commentary Big knowledge from big data in functional genomics Chris P.
  • Symposium 2019 Booklet 4Website II.Pdf

    Symposium 2019 Booklet 4Website II.Pdf

    CONTENTS Foreword……………………………………………………………………………………… 3 Symposium programme ………………………………………………………………. 4 Meet our speakers ……………………………………………………………………….. 5 Student abstracts …………………………………………………………………………. 9 Theme 1: Genetic Processes and Proteins ………………………….. 10 Theme 2: Environmental Biology and Ecology …………………… 17 Theme 3: Health and Nutrition …………………………………………... 23 Theme 4: Fundamental meets Synthetic Biology ………………… 29 Theme 5: Body Brain and Behaviour ………………………………….. 34 Poster design: © Liat Adler 2 Welcome to the EASTBIO Annual Symposium 2019 A very warm welcome to attendees at the 2019 Annual Symposium of the BBSRC-funded EASTBIO Doctoral Training Partnership. The Annual Symposium represents one of the highlights in the EASTBIO calendar. The theme of this year’s conference is ‘Bioscience Research: To Biology and Beyond!’ The two-day Symposium brings together guest speakers and four cohorts of our PhD students to discuss the broad range of interdisciplinary research conducted across the partnership spanning from bioscience for health to biotechnology and food security. We hope you will enjoy the proceedings! Dr Edgar Huitema School of Life Sciences, University of Dundee On behalf of the EASTBIO Management Group & the Symposium Organising Committee 3 EASTBIO ANNUAL RESEARCH SYMPOSIUM: TO BIOLOGY AND BEYOND! University of Dundee, Dalhousie Building - 13-14 June 2019 Day 1 Schedule – 13 June 2019 10:30 Registration & coffee/tea The Street, School of Life Sciences - note different venue 11:00-11:10 Welcome & Introduction Dalhousie, Lecture
  • MRC - the University of Edinburgh

    MRC - the University of Edinburgh

    MRC - The University of Edinburgh DOCTORAL TRAINING PROGRAMME IN PRECISION MEDICINE PROJECT PROPOSALS March 2016 Information on the DTP in Precision Medicine: http://www.ed.ac.uk/medicine-vet-medicine/postgraduate/research- degrees/phds/precision-medicine Apply online: http://www.ed.ac.uk/studying/postgraduate/degrees/index.php?r=site/view&id= 919 Project title: Towards patient stratification at point of care using rapid microRNA detection Project description: Background Paracetamol (acetaminophen) overdose is one of the most common reasons for emergency hospital attendance and is the leading cause of acute liver failure in the Western world. Annually across the UK paracetamol overdose results in approximately 100,000 Emergency Department presentations and 50,000 acute hospital admissions. To put this workload in context, these numbers are larger than admissions due to heart attacks. The current approach to treatment is sub-optimal predominately due to an inability to stratify patients and identify those who stand to benefit from treatment. At present, too many patients are being admitted to hospital for unnecessary treatment with the antidote (NAC) because current blood tests cannot rule out liver damage in the emergency department. Therefore, there is an unmet clinical need for markers that can target treatment only to those who stand to benefit and rule out liver damage earlier than is currently possible. We have addressed these important limitations by identifying a new blood biomarker (microRNA-122 ‘miR-122’) that is more sensitive and specific for liver injury than all standard tests and accurately reports injury at first presentation to hospital, a time when current blood tests are often still in the normal range.1,2 The key roadblock to further clinical development - specifically using miR-122 in stratified clinical trials lead by our pharma partners - is the lack of a rapid point of care assay.
  • Transposable Elements: Are They Lynne Harris, University of Edinburgh Good for You After All? Ordinary Committee Members Genetics Society Sponsored Events 26 - 35 Dr

    Transposable Elements: Are They Lynne Harris, University of Edinburgh Good for You After All? Ordinary Committee Members Genetics Society Sponsored Events 26 - 35 Dr

    Issue 65.qxd:Genetic Society News 27/6/11 10:06 Page 1 JULYJULLYY 2011 | ISSUE 65 GENETICSGENNETICSS SOCIETYSOCIEETY NENEWSEWS In this issue The Genetics Society News is edited s Spring Meeting by David Hosken and items for futurfuturee s SponsoredSponsored Meetings Meetings issues can be sent to the editoreditor,, by email to [email protected]@exeter.ac.uk.exeter.ac.uk. s Summer Student and TravelTravel Reports The Newsletter is publishedblished twice a s 2012 AwardsAwards Announced Announced yearyear,, with copy dates of 1st June s Edinburghg 2012 and 26th NovemberNovember.. The 2012 Genetics SpringSprinng Meeting Supermodel Organisms: Chemical Genetics and Synthetic LifeLiffe See page 5 for registrationregistratiion information Issue 65.qxd:Genetic Society News 27/6/11 10:06 Page 2 A WORD FROM THE EDITOR A word from the editor Welcome to issue 65. interested, search for and read “Promiscuity is key to survival” As usual this issue is packed and then read the research full of interesting reports from underpinning it as one case in students, young researchers point. and we have meetings reports past and future! Thanks once Perhaps the quality of science again to all of those who kindly reporting is partly why non- contributed. As is usual in the scientists, and administrators Editorial, it’s time to wax in particular, think they should lyrical, and there are two and can direct research. This is themes I want to mention here, not new, but as public spending science journalism and cuts continue in the UK, calls to deciding who should determine direct research are becoming many headed shotgun approach the research to be funded by more vociferous, with because no one knows where the taxpayer, as in a way they bureaucrats rather than the next break through will be, are linked.
  • Transcriptional Regulatory Functions of Nuclear Long Noncoding Rnas', Trends in Genetics, Vol

    Transcriptional Regulatory Functions of Nuclear Long Noncoding Rnas', Trends in Genetics, Vol

    Citation for published version: Vance, KW & Ponting, CP 2014, 'Transcriptional regulatory functions of nuclear long noncoding RNAs', Trends in Genetics, vol. 30, no. 8, pp. 348-55. https://doi.org/10.1016/j.tig.2014.06.001 DOI: 10.1016/j.tig.2014.06.001 Publication date: 2014 Document Version Publisher's PDF, also known as Version of record Link to publication Publisher Rights CC BY University of Bath Alternative formats If you require this document in an alternative format, please contact: [email protected] General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 28. Sep. 2021 Review Transcriptional regulatory functions of nuclear long noncoding RNAs Keith W. Vance and Chris P. Ponting MRC Functional Genomics Unit, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, OX1 3PT, UK Several nuclear localised intergenic long noncoding lncRNAs function at their sites of synthesis to regulate RNAs (lncRNAs) have been ascribed regulatory roles in local gene expression transcriptional control and their number is growing Intergenic lncRNAs have been divided, on the basis of rapidly. Initially, these transcripts were shown to func- chromatin marks at their promoters, into two broad cate- tion locally, near their sites of synthesis, by regulating gories: those emanating from enhancer regions or those the expression of neighbouring genes.
  • The Biology of Genomes

    The Biology of Genomes

    Abstracts of papers presented at the 2010 meeting on THE BIOLOGY OF GENOMES May 11–May 15, 2010 Cold Spring Harbor Laboratory Cold Spring Harbor, New York Abstracts of papers presented at the 2010 meeting on THE BIOLOGY OF GENOMES May 11–May 15, 2010 Arranged by Susan Celniker, Lawrence Berkeley National Laboratory Andy Clark , Cornell University Chris Ponting, University of Oxford, UK George Weinstock, Washington University School of Medicine Cold Spring Harbor Laboratory Cold Spring Harbor, New York Major sponsorship for this meeting was provided by Roche. Additional funding provided by Illumina, Inc., and the National Human Genome Research Institute, a branch of the National Institutes of Health. Contributions from the following companies provide core support for the Cold Spring Harbor meetings program. Corporate Sponsors Agilent Technologies AstraZeneca BioVentures, Inc. Bristol-Myers Squibb Company Genentech, Inc. GlaxoSmithKline Hoffmann-La Roche Inc. Life Technologies (Invitrogen & Applied Biosystems) Merck (Schering-Plough) Research Laboratories New England BioLabs, Inc. OSI Pharmaceuticals, Inc. Sanofi-Aventis Plant Corporate Associates Monsanto Company Pioneer Hi-Bred International, Inc. Foundations Hudson-Alpha Institute for Biotechnology Cover: Illustration by Marty Macaluso, www.quicksketch.com. THE BIOLOGY OF GENOMES Tuesday, May 11 – Saturday, May 15, 2010 Tuesday 7:30 pm 1 Functional and Cancer Genomics Wednesday 9:00 am 2 Genetics of Complex Traits Wednesday 2:00 pm 3 Poster Session I Wednesday 4:30 pm Wine and Cheese
  • Big Knowledge from Big Data in Functional Genomics

    Big Knowledge from Big Data in Functional Genomics

    Edinburgh Research Explorer Big knowledge from big data in functional genomics Citation for published version: Ponting, C 2017, 'Big knowledge from big data in functional genomics', Emerging Topics in Life Sciences . https://doi.org/10.1042/ETLS20170129 Digital Object Identifier (DOI): 10.1042/ETLS20170129 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Emerging Topics in Life Sciences Publisher Rights Statement: This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and the Royal Society of Biology and distributed under the Creative Commons Attribution License 4.0 (CC BY). General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 05. Apr. 2020 Emerging Topics in Life Sciences (2017) 1 245–248 https://doi.org/10.1042/ETLS20170129 Commentary Big knowledge from big data in functional genomics Chris P. Ponting MRC Human Genetics Unit, The Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, U.K.
  • 2013 Fellowship Election Results

    2013 Fellowship Election Results

    6/14/13 Academy of Medical Sciences - May 2013 - Newsletter 2013 Fellowship election results 44 of the UK’s leading medical researchers have been recognised for excellence in medical science with their election to the Academy Fellowship. These distinguished scientists bring the total number of Academy Fellows to 1095. We offer the new Fellows our warmest congratulations on their election and welcome them to the Academy. The Fellows will be formally admitted during a ceremony on Wednesday 26 June. All Fellows are warmly invited to attend the day’s events. As well as the election of new Fellows, the day includes presentations from four new Fellows and a keynote lecture from Professor Peter Ratcliffe FRS FMedSci. This year Admission Day will be held at The Royal Society and the day will conclude with the annual Fellows summer soirée. Fellows elected in 2013 Dr Facundo Batista, Lead Researcher, Lymphocyte Interaction Laboratory, London Research Institute, Cancer Research UK Professor David Beech,Professor of Cardiovascular Science, University of Leeds Professor Gurdyal Besra, Bardrick Professor of Microbial Physiology and Chemistry, University of Birmingham Professor Barbara Casadei, British Heart Foundation Professor of Cardiovascular Medicine and Hon. Consultant Cardiologist, University of Oxford Professor Jane Clarke, Wellcome Trust Senior Research Fellow in Basic Biomedical Science and Professor of Molecular Biophysics, University of Cambridge For further information contact Professor Garth Cooper, Professor in Discovery and Experimental